Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patients.

Int J Chron Obstruct Pulmon Dis · 2018 · PMC6186765 · PMID 30349227

Europe PMC DOI

hedged sentence

0.4000

closest p · 8.0× alpha

0.4000

boldest claim

The sentences

did not reach statistical significanceP =0.40not close (p > 0.1)

Meanwhile, the proportion of both PD-1 + CD4 + T cells (12.49±1.82 vs 9.97±1.55) and PD-1 + CD8 + T cells (4.01±0.51 vs 2.29±0.44) was greater in COPD patients than non-COPD subjects, although the difference in CD4 + T cell percentage did not reach statistical significance ( P =0.40; Figure 5C and D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.